Come and see us at Festival of Biologics in Basel. Visit our booth 604 and hear Marc Smith, Director of Strategic Solutions, speak.
Find out more about how we meet the challenges of research, development and manufacturing data management.
Find out more about how we meet the challenges of research, development and manufacturing data management.
Learn how to overcome manufacturing data challenges with IDBS at this year’s event in Singapore. We look forward to seeing you there!
Join our webinar, on October 18, and learn how the Polar Platform can support the multi-tiered approach to assessing ADAs through a combination of planning, execution and reporting workflows.
Robust digital workflows in pharma lifecycle management can reduce errors and time to compile data, speeding up regulatory filing.
Come and join us in San Diego, to learn how an innovative tech transfer approach can revolutionize drug manufacturing in the pharmaceutical industry.
Come and join us at booth D8 in Amsterdam, to hear Alberto present on how contextualized product and process data is critical for empowering decisions throughout the drug development lifecycle.
Come and join us at booth #3044 in Orlando to learn how Polar is designed to efficiently navigate the complex landscape of processes and data with turnkey analytics and visualization for deep process understanding.
Digital initiatives in BPLM provide an opportunity to modernize legacy processes and replace labor-intensive and time-consuming manual methods.
Come and join us at booth 660 in Boston, to learn how an innovative tech transfer approach can revolutionize drug manufacturing in the pharmaceutical industry.
Practical steps for improving manufacturing process and batch data exchange to create greater transparency and data integrity.
Learn how advances in digital technology and the tailwinds of external forces offer the pharma industry a chance to break out of this paradox.
To bring new therapies to the patients faster, we need to bring people, processes and data together across the full pharma process development lifecycle.
Making data a core deliverable means the right people need to collect information and connect disparate data points through a well-structured data backbone.
Explore why digital maturity is key to transparency and collaboration and enabling accurate forecasting throughout the BioPharmaceutical lifecycle.
The BioPharma industry is facing a multitude of challenging external trends, from the growth in personalized medicine to supply chain disruptions and more.
Explore the benefits of GxP computer systems to improve time-to-value so that companies can speed up the development and manufacture of life-saving drugs.
IDBS reveals new process definition-handling capabilities in PIMS 5.0, which enhance quality assurance and validation for pharma manufacturers.
A digital data backbone is key to a successful instrument data integration, speeding processes so that companies can get their therapies to market faster.
Digital workflows with an “audit-by-exception” approach help reduce errors and time to compile data, and therefore delays to market.
Accelerating tech transfer is vital with new precision medicine and increasing regulatory scrutiny of product quality and management of external partners.
Come and join us at PEGS Boston, booth 302, to learn how Polar workflows simplify the BioPharma lifecycle with process-aware planning, design and execution of end-to-end bioprocess and analytics unit operations.
Come and join us at ABS, booth 44, to learn how Skyland PIMS can help improve your team’s operational efficiency via a single source for simplified process monitoring.
IDBS and SciBite announce a new partnership to shift the way research data platforms approach FAIR (Findable, Accessible, Interoperable, and Reusable) data.
IDBS announces the launch of new data science capabilities for its Polar platform to accelerate BioPharma process optimization.
Meet and speak to our experts to learn how our cloud-native Skyland PIMS software helps both sponsors and CMOs/CDMOs seamlessly share processes and process data in the same environment. Data can be securely and instantly shared while restricting visibility on a need-to-know basis. This single source of truth both speeds up and reduces risk to the tech transfer process, and its intended outcomes.
Come and join us at SLAS 2023 to learn how Polar can help you navigate your biopharma lifecycle
Come and join us at BPI West to learn how Polar can help you navigate you biopharma lifecycle and how Skyland PIMS can help accelerate your biopharma development and manufacturing.
Data silos and inconsistent data formats increase the chance of errors, which can have a significant impact on business operations. Digital workflows are the answer.
Explore how cloud-based solutions can improve data visibility and transparency so that partners can enjoy equal access to data at all stages of the BioPharma lifecycle.
Do you have a vision for clean, contextualized data? Is IT accountable to the bench in your lab? Are you willing to value even the most unassuming insights?
Maintaining the balance between compliance and efficiency is what will set a CRO apart in the highly competitive outsourcing landscape and inspire the sponsor’s confidence.
Drug sponsors value – and rely on – the work that CROs perform. CROs have a chance to up their data management game. How can they ensure data quality?
Learn the importance of enterprise control in getting CGTs to market – and the critical systems that enable this control in cell-based therapy manufacturing.
From ensuring data integrity to consolidating IP ownership, effective data management is key for BioPharma companies seeking a competitive edge.
Join us on the 30th November, to discuss best practices for addressing this challenge and explore the use of innovative solutions to streamline process data management with higher data integrity, support accelerated tech transfer between development and manufacturing, and drive collaboration among internal and external teams.
A cloud-only approach provides many benefits, including streamlined validation, automated backups and upgrades, faster deployments and flexibility.
A digital data backbone can improve efficiency in the research process leading to earlier discoveries and lower costs. Discover how now.
IDBS will be exhibiting in the event this year in Orlando, FL, at booth #1138. We look forward to seeing you there!
IDBS attended EBF in Barcelona. You can still book a meeting with one of our specialists.
Successful tech transfer can be a challenge, even for well-established biotechs. Here’s how to avoid common pitfalls at every stage.
Modernized data governance ensures a solid foundation of data integrity and compliance and achieves an integrated approach to the BioPharma data lifecycle.
Now that we know what a microservice is and why it’s important, let’s explore deploying and managing cloud microservices in GxP environments.
Speeding up time to insight throughout the BioPharma lifecycle requires all data sources to be connected and utilized to form a robust data backbone.
What is a microservice? Let’s explore the term’s meaning, the benefits and how it can help boost your data security.
Life science companies rely on data integrity, security and transparency to ensure success. How do we protect data while keeping it accessible?
BioProcess International took place in Vienna this year, with talks centred around six main streams including cell line development and engineering, cell culture, recovery and purification, viral safety, cell and gene therapy as well as smaller sessions for manufacturing strategy and Industry 4.0 and vaccine manufacturing.
IDBS, a global life sciences software company and the leading innovator in BioPharma Lifecycle Management (BPLM), is excited to bring together over 200 customers, partners and industry experts, including leading CxO and BioPharma companies, at their annual i3 user conference.
In the quest to develop the science and raise funding, developing a digital strategy in general is an afterthought for fledgling biotech companies – if it’s considered at all. Not paying attention to it early, however, can hamper their ability to advance their science and constrain their revenue-generation options.
IDBS will be presenting at the conference this year in Vienna. We look forward to being back at Bioprocess in-person events in 2022.
Modern BioPharma development requires more than just a LIMS and spreadsheets. Learn why in this article by Alberto Pascual, IDBS, featuring Accenture and published in Lab Manager.
IDBS announces the latest release of its Skyland PIMS software, which seamlessly combines product, process, and patient data across the BioPharma life cycle and supply chain, providing insights that accelerate process understanding and ensure product quality.
Accelerate process understanding and time-to-insight across your development and manufacturing lifecycle. Join us at booth #21 at the Biomanufacturing World Summit in San Diego, USA.
IDBS will be running our annual experience event, i3, again in June this year!
As the biopharmaceutical industry begins to embrace advanced data collection and analysis tools, it finds itself facing a challenging question: How can drug manufacturers best harness all that data to improve capacity, reduce bottlenecks and cut costs?
IDBS will be running our annual experience event, i3, again in June this year!
IDBS will be presenting at the event this year in San Francisco, CA. We look forward to seeing you there!
The pandemic exposed the innovation divide between the digitally transformed and those that lagged. Strict regulation made life sciences and BioPharma organizations hesitant to modernize too quickly away from proven legacy methods and technologies, resulting in varying levels of digital transformation. But are they missing out?
Join us for an interesting roundtable discussion around how to build a solid foundation for advanced analytics and why legacy ELN/LIMS aren’t suitable for modern biopharma because they don’t support the data backbone concept. Hear from experts at Accenture, GSK and IDBS and gather insight from experiences close to the ever evolving market.
Throughout the past few years, there’s been a clear trend in the makeup of approvals, with biologics representing a growing percentage. But even within biologics, newer technologies like mRNA, cell, and gene therapies are gaining ground. The approvals are not one-off events, but evidence of an exciting long-term trend. Learn more from Christian Marcazzo, General Manager at IDBS, in his article published in Drug Development & Discovery.
IDBS will be presenting at the event this year in Berlin, Germany. We look forward to seeing you there!
A top ten CRO (Contract Research Organization) has chosen IDBS’ Polar™ BioPharma Lifecycle Management to achieve its goal of faster biopharma development.
IDBS will be presenting at the conference this year in Boston, MA. We look forward to being back at Bio-IT in person and virtually in 2022.
Around this time last year, the first COVID-19 vaccines were authorized for emergency use. A year before that, COVID-19 had not yet been declared a pandemic. It goes to show how much can change in this industry, as well as how important this sector is. Hear predictions from experts, including Alberto Pascual, in this article, published in Drug Discovery World.
For those of us who develop software that supports the biopharmaceutical/life science industry, the challenges and opportunities in digital transformation are painfully obvious and it can be easy to forget that not everyone sees it that way. Let’s try another way…
IDBS will be presenting at the conference this year in San Diego, California. We look forward to being back at Bioprocess in-person events in 2022.
This webinar will discuss the progress made in the operational analytics and data space and the real benefits to its system administrators and speadsheet data consumers. E-WorkBook Cloud and Polar customers will learn about the capabilities available to them. And E-WorkBook on-premise customers will learn about some business benefits of migrating to the cloud as well.
While 2021 was another challenging year in many respects, the life science industry still managed some notable achievements.
Tomorrow’s Connection Today – Designing a new future for manufacturing, quality and supply chain leaders. We will be attending the European Biomanufacturing Summit virtual conference on February 8-10, 2022.
Watch our webinar, Managing the Journey from Process Development to Insight, where you will learn how to build the right foundation to ensure confidence in the accuracy and availability of your data, understand how to get actionable insights from your bioprocess data to maximize cell culture productivity, and discover how digital workflows with embedded integrations can curate a process data backbone that speeds time-to-insight with advanced data analytics and visualization tools.
Join Henry Charlton, Commercial Director Biologics to learn how to build the right foundation to ensure confidence in the accuracy and availability of your data, understand how to get actionable insights from your bioprocess data to maximize productivity, and discover how digital workflows with embedded integrations can curate a process data backbone that speeds time-to-insight and time to commercial readiness with advanced data analytics and visualization tools.
IDBS, a global life sciences software company and Synthace, a pioneer software for automated biology experimentation and insight sharing, have entered a strategic partnership to provide IDBS Polar users with state-of-the-art data foundations for experimentation in high-throughput process development (HTPD).
IDBS, a Danaher (NYSE:DHR) operating company, announced Polar Insight, bringing new advanced data analytics and visualization tools to the Polar BioPharma Lifecycle Management (BPLM) platform. Extracting valuable insights from process and quality data across the biopharmaceutical lifecycle is a time consuming and error prone process, requiring laborious manual work and multiple steps.
Global life sciences software company IDBS announces the acquisition of biopharmaceutical manufacturing data management and analytics software developer Skyland Analytics, in a move that will create the first BioPharma Lifecycle Management (BPLM) offering that supports therapies from early development through commercial manufacturing.
Global life sciences software company IDBS announces the acquisition of biopharmaceutical manufacturing data management and analytics software developer Skyland Analytics, in a move that will create the first BioPharma Lifecycle Management (BPLM) offering that supports therapies from early development through commercial manufacturing. Skyland Analytics is best known for its Skyland PIMS™ software which seamlessly combines product, process, and patient data across the biopharma lifecycle and supply chain, providing insights that accelerate process understanding and ensure product quality.
When you factor in the unpredictability and complexity of therapies like biologics, the time impacts of poorly managed data are on the order of 6–18 months. Find out more on why legacy data management systems can’t support the directions…
The global community await to hear what the accelerated response to climate change will be from the COP26 Summit starting on Sunday in Glasgow. Here at IDBS we know that identification of true reductions in environmental impact through process modelling and Life Cycle Assessment can only be made with access to quality data. Find out more in our blog.
Join over 400 scientific leaders at Cell UK: In-Person Congress, connecting regenerative medicine and bioprocessing experts to transform cell research and therapies.
IDBS, the leading innovator in BioPharma Lifecycle Management (BPLM), announces its membership of BioPhorum. BioPhorum offers a space where biopharmaceutical manufacturers and suppliers can come together and discuss the many challenges in the industry, working collaboratively to address them. IDBS has joined the Information Technology Phorum (BPIT) which specifically addresses IT business goals.
Europe’s leading bioprocessing event for accelerating biologics, mAbs, vaccines and novel products to commercial success. Access leading science, technologies and contacts across the entire bioprocessing spectrum.
The biopharma industry may have been slow to embrace digital technologies, but it’s catching up fast. The innovation we’re seeing in predictive modeling and machine learning could truly revolutionize the entire lifecycle of drug discovery and development. Take a…
Life sciences companies are using digital twins for everything from drug discovery to manufacturing. Hear from a panel of experts at MedCity News’ INVEST Digital Health conference, moderated by Accenture, where companies, including IDBS, discuss how this capacity to…
This session will provide an overview of IDBS’s upcoming plans to embed the DLX platform within E-WorkBook Cloud to provide a scalable, enterprise-grade integration backbone for lab connectivity and workflow orchestration. Following the overview, there will be an open forum to discuss some of the challenges in delivering lab integration at scale and feedback on workflows / instrument classes that should be considered for initial prioritization.
IDBS is excited for its upcoming analytics launch and will update attendees to the progress made in this space which will have real benefits to its system administrators and spreadsheet data consumers. E-WorkBook Cloud and Polar customers will learn about new capabilities soon available to them – and E-WorkBook on-premise customers will learn about some business benefits of migrating to the cloud.
Join IDBS’ Alberto Pascual for this roundtable discussion, The Role of Digital Twins in Life Sciences, at the MedCity INVEST Digital Health virtual conference.
In the biopharmaceutical industry, there’s no shortage of data—the issue organizations more often face is how to capture data in ways that derive insight from it. As more and more companies are now recognizing, a fundamentally different approach is…
IDBS, a leading R&D technology and solutions provider and Tableau, the world’s leading analytics platform, announced a strategic partnership to integrate Tableau into the IDBS suite of products. The collaboration will be based on embedding Tableau’s visual and analytics capabilities into the IDBS product offerings.
Roundtable Discussion | IDBS Hosts the Best Practices in Bioanalysis Lab Informatics. Hear how industry experts like Nexelis, AbbVie, and ICON plc are tackling digital lab challenges
Alberto Pascual, IDBS, tells MedCity News how digital twins can help advance innovation in R&D…
In this webinar IDBS will share how an innovative approach to biopharma lifecycle management supports true QbD and can accelerate development to bring products to market faster.
One of the lasting legacies of the COVID-19 pandemic is heightened awareness of manufacturing challenges and supply chain vulnerabilities in the biopharma industry and the impact this can have on public health. Issues have occurred at every stage of the supply chain, from the availability of raw materials to quality concerns with active pharmaceutical ingredients (APIs), and finished dosage forms and restrictive cold chain requirements.
Join Alberto Pascual, IDBS’s Director of Data Science and Analytics where he will discussing how you can join the digital transformation revolution by democratizing the use of advance analytics!
In a recent Forbes article, Danaher’s Chief Science officer, Jose-Carlos Gutierrez-Ramos, described the impact of the COVID-19 pandemic as follows:“I believe the biopharma business model has fundamentally changed.
IDBS has always listened to its customers and used the feedback gathered to guide the development of product capabilities. In fact, it is one of Danaher’s core values. Being part of Danaher’s Life Sciences arm has reaffirmed the value and we are constantly looking to improve based on customers’ feedback.
IDBS are delighted to presenting at The 2nd Quality Science of Biologics Summit in Beijing on the 25th May. We hope to see you there!
Biopharma 4.0 is a bold vision, with smart factories and process automation, driven by real time data to constantly ensure quality and efficiency. The journey towards this vision starts with improving process understanding and characterization, supported by advances in…
In this webinar, Henry Charlton, Commercial Director of Biologics Development at IDBS will share how effective biopharma lifecycle management can drive speed and innovation in process development as labs struggle with the increases in data from equipment, instruments and sensors.
A Week of Bioanalysis, Biomarkers, Immunogenicity, Gene Therapy, Cell Therapy & Vaccines
Meet us virtually for the 15th WRIB Annual Conference where high quality, better compliance to regulations and scientific excellence have always been the foundations of WRIB.
TetraScience, the world’s first and only open R&D Data Cloud for scientific discovery, and IDBS, a leading R&D technology and solutions provider, announce a strategic partnership to integrate IDBS E-WorkBook and Tetra Data Platform into a common ecosystem to provide end-to-end R&D data automation.
LabVoice, which provides a workflow engine for scientific voice assistants, and IDBS, a leading R&D technology and solutions provider, are excited to announce an integration to accelerate research, innovation, and design.
IDBS, the leading innovator in BioPharma Lifecycle Management (BPLM), today announced the launch of Polar BioAnalysis, bringing consistency, quality, and reproducibility to preclinical drug qualification.
Asia’s leading bioprocessing event for learning how to drive down costs, improve timelines, and navigate the regulatory landscape for your biologics and novel modalities.
Learn How BioProcessing Experts are Increasing Quality, Process Efficiency and Productivity While Decreasing Costs to Achieve Commercial Success
Join Henry Charlton, Commercial Director, Biologics Development for for IDBS, at 11:00 am (JST) on April 6th to hear about the bold Biopharma 4.0 vision. Learn how to accelerate your cell culture development with biopharma lifecycle management.
The leading virtual event for learning how to improve process efficiencies and maintain product quality across all phases of bioprocessing.
Join Unjulie Bhanot, Solution Owner for IDBS, at 11:55 am PST on March 31 to hear about the bold Biopharma 4.0 vision. Learn how to accelerate your cell culture development with biopharma lifecycle management.
The global pandemic is shining a spotlight on the power of biologics, both vaccines and antibody therapeutics, to prevent serious infections and treat disease.
The licensing and integration of Scitara DLX technology will offer IDBS users plug-and-play connectivity to any instrument or application in regulated and non-regulated laboratories
The collaboration will enable direct integration of IDBS digital solutions with the Genedata Biopharma Platform, accelerating the discovery and development of next-generation biotherapeutics Basel, Switzerland & Boston, MA, USA — January 12, 2021 — Genedata and IDBS, both…
Guildford, UK and Framingham, MA, September 9th, 2020 – IDBS announced today that it has released a fully-featured integration between the E-WorkBook electronic laboratory notebook (ELN) and SCIEX Analyst® Software, expanding IDBS’s existing family of integrations. This new…
The ultimate goal in the biopharma space, especially for vaccine manufacturers, is producing safe and effective therapies faster, and at a lower cost. Many professionals still believe that their competitive edge relies on technical improvement, but it’s more complicated than that…
Join us at PEGS Boston, the leading conference & expo where world-renowned experts, visionaries, and influencers from top pharma, biotech, academic, and government institutions convene every year to transform the future of biologics. You can find us at the exhibit…
In response to the outbreak, governments around the world have put strict measures in place to limit the spread of the virus – Italy was the first country to order a country-wide lock down, France closed its borders and PM…
A Week of Bioanalysis, Biomarkers, Immunogenicity, Gene Therapy & Vaccine Assays High quality, better compliance to regulations and scientific excellence are always the foundations of this workshop. IDBS helps deliver consistency, quality and reproducibility for Preclinical…
BioAsia 2020 explores the capabilities that Life sciences companies should invest in today to thrive and create value tomorrow. Globally, the rise of more informed healthcare consumers, new technologies, and ubiquity of data and analytics continues to blur the…
Increase efficiency, enhance connectivity and drive superior quality in the modern lab. We’re delighted to be partnering with IQPC again in 2020 to bring you SmartLab Digital on 11th and 12th March. SmartLab Digital is a complimentary online series…
IDBS, a software informatics solution provider for biotech and pharma, has expanded its global reach in India and made two strategic hires in the region. The latest move by the firm is in response to growing demand and an expanding…
In recent years, gene therapies, gene-modified cell therapies and cell therapies, collectively known as ‘Advanced Therapies’, have rapidly become an integral part of the R&D programs of many Biopharmaceutical companies. This is illustrated by some of the key trends…
This year BioProduction Congress merges with bioLIVE to become BioProduction at CPhI Worldwide. BioProduction will be co-located with CPhI Worldwide in Frankfurt, 5th-7th November 2019 – the largest pharmaceutical event in the world – uniting biotech, pharma, and solution…
IDBS becomes the first Electronic Lab Notebook provider to achieve SOC 2 compliance IDBS has achieved compliance with SOC 2, following an audit by CyberGuard Compliance, LLC to the American Institute of Certified Public Accountants’ (AICPA) Trust Services Criteria…
The biopharmaceutical industry continues to grow and isn’t showing any signs of slowing down. Last year, we talked about different aspects of the biopharmaceutical industry. These touched on several trends from the importance of data and the extensive use…